Drug Approvals Will Be Down “Significantly” In ’05, FDA’s Gottlieb Predicts

The number of new molecular entities approved by FDA in 2005 will be significantly fewer than in recent years, Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb predicted